Institute of Pharmacology and Toxicology, Department of Biomedical Sciences, University of Veterinary Medicine, Vienna, Austria.
Department of Environmental Geosciences, University of Vienna, Vienna, Austria.
Biochem Pharmacol. 2020 Mar;173:113737. doi: 10.1016/j.bcp.2019.113737. Epub 2019 Nov 29.
Endoperoxides (EPs) appear to be promising drug candidates against protozoal diseases, including malaria and leishmaniasis. Previous studies have shown that these drugs need an intracellular activation to exert their pharmacological potential. The efficiency of these drugs is linked to the extensive iron demand of these intracellular protozoal parasites. An essential step of the activation mechanism of these drugs is the formation of radicals in Leishmania. Iron is a known trigger for intracellular radical formation. However, the activation of EPs by low molecular iron or by heme iron may strongly depend on the structure of the EPs themselves. In this study, we focused on the activation of artemisinin (Art) in Leishmania tarentolae promastigotes (LtP) in comparison to reference compounds. Viability assays in different media in the presence of different iron sources (hemin/fetal calf serum) showed that IC values of Art in LtP were modulated by assay conditions, but overall were within the low micromolar range. Low temperature electron paramagnetic resonance (EPR) spectroscopy of LtP showed that Art shifted the redox state of the labile iron pool less than the EP ascaridole questioning its role as a major activator of Art in LtP. Based on the high reactivity of Art with hemin in previous biomimetic experiments, we focused on putative heme-metabolizing enzymes in Leishmania, which were so far not well described. Inhibitors of mammalian heme oxygenase (HO; tin and chromium mesoporphyrin) acted antagonistically to Art in LtP and boosted its IC value for several magnitudes. By inductively coupled plasma methods (ICP-OES, ICP-MS) we showed that these inhibitors do not block iron (heme) accumulation, but are taken up and act within LtP. These inhibitors blocked the conversion of hemin to bilirubin in LtP homogenates, suggesting that an HO-like enzyme activity in LtP exists. NADPH-dependent degradation of Art and hemin was highest in the small granule and microsomal fractions of LtP. Photometric measurements in the model Art/hemin demonstrated that hemin requires reduction to heme and that subsequently an Art/heme complex (λ 474 nm) is formed. EPR spin-trapping in the system Art/hemin revealed that NADPH, ascorbate and cysteine are suitable reductants and finally activate Art to acyl-carbon centered radicals. These findings suggest that heme is a major activator of Art in LtP either via HO-like enzyme activities and/or chemical interaction of heme with Art.
内过氧化物(EPs)似乎是一种很有前途的药物候选物,可以治疗原生动物疾病,包括疟疾和利什曼病。先前的研究表明,这些药物需要在细胞内激活才能发挥其药理潜力。这些药物的效率与这些细胞内原生动物寄生虫对铁的大量需求有关。这些药物激活机制的一个重要步骤是在利什曼原虫中形成自由基。铁是细胞内自由基形成的已知触发因素。然而,EPs 被低分子铁或血红素铁激活可能强烈依赖于 EPs 本身的结构。在这项研究中,我们专注于青蒿素(Art)在塔兰托利什曼原虫(LtP)前鞭毛体中的激活,与参考化合物进行比较。在不同铁源(血红素/胎牛血清)存在的不同培养基中的细胞活力测定表明,Art 在 LtP 中的 IC 值受测定条件的调节,但总体上处于低微摩尔范围内。LtP 的低温电子顺磁共振(EPR)光谱显示,Art 对不稳定铁池的氧化还原状态的影响小于 EPs 青蒿琥酯,这质疑了它作为 LtP 中 Art 的主要激活剂的作用。基于 Art 在先前仿生实验中与血红素的高反应性,我们专注于利什曼原虫中尚未很好描述的假定血红素代谢酶。哺乳动物血红素加氧酶(HO;锡和铬中卟啉)的抑制剂(tin and chromium mesoporphyrin)在 LtP 中与 Art 拮抗作用,并将其对 Art 的 IC 值提高了几个数量级。通过电感耦合等离子体方法(ICP-OES、ICP-MS),我们表明这些抑制剂不会阻止铁(血红素)的积累,而是被摄取并在 LtP 中发挥作用。这些抑制剂阻断了 LtP 匀浆中血红素向胆红素的转化,表明 LtP 中存在类似 HO 的酶活性。NADPH 依赖性 Art 和血红素的降解在 LtP 的小颗粒和微粒体部分最高。在 Art/血红素模型中的光度测量表明,血红素需要还原为血红素,随后形成 Art/血红素复合物(λ 474nm)。Art/血红素体系中的 EPR 自旋捕获表明,NADPH、抗坏血酸和半胱氨酸是合适的还原剂,最终将 Art 激活为酰基碳中心自由基。这些发现表明,血红素通过类似 HO 的酶活性和/或血红素与 Art 的化学相互作用,是 LtP 中 Art 的主要激活剂。